Frontiers in endocrinology

GLP-1 drugs and the risk of kidney injury after heart procedures in people with Type 2 diabetes

Updated

Abstract

Contrast-induced acute kidney injury (CI-AKI) occurs frequently in patients undergoing coronary procedures, especially those with type 2 diabetes mellitus (T2DM).

  • CI-AKI is a common complication associated with coronary angiography and percutaneous coronary intervention.
  • Patients with type 2 diabetes mellitus (T2DM) are particularly vulnerable to CI-AKI.
  • Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are suggested to have potential renoprotective effects.
  • Current evidence regarding the effects of GLP-1 RAs in contrast exposure is limited.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free